Quick Answer
ClearPoint Neuro, Inc. reported Operating Income of -$24.16 million for fiscal year 2025.
ClearPoint Neuro, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$24.16M | -22.4% |
| 2024 | -$19.73M | +12.1% |
| 2023 | -$22.45M | -37.4% |
| 2022 | -$16.33M | -22.1% |
| 2021 | -$13.37M | -115.0% |
| 2020 | -$6.22M | -35.4% |
| 2019 | -$4.59M | +12.5% |
| 2018 | -$5.25M | +17.2% |
| 2017 | -$6.34M | +15.4% |
| 2016 | -$7.49M | +16.6% |
| 2015 | -$8.97M | -68.7% |
| 2014 | -$5.32M | +28.8% |
| 2013 | -$7.47M | -138.9% |
| 2012 | -$3.13M | +47.2% |
| 2011 | -$5.92M | +37.8% |
| 2010 | -$9.52M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.28M | -2.3% | +7.1% |
| June 30, 2025 | -$5.68M | -20.2% | +7.8% |
| March 31, 2025 | -$6.16M | -46.2% | -19.5% |
| September 30, 2024 | -$5.16M | -5.3% | -9.2% |
| June 30, 2024 | -$4.72M | +33.8% | -12.0% |
| March 31, 2024 | -$4.22M | +26.2% | +13.9% |
| September 30, 2023 | -$4.90M | -29.0% | +31.3% |
| June 30, 2023 | -$7.13M | -69.6% | -24.8% |
- ClearPoint Neuro, Inc. showed a decrease of -22.4% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, ClearPoint Neuro, Inc.’s operating income has declined by 153.9% (from -$9.52 million to -$24.16 million).
- The most recent figure is from ClearPoint Neuro, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: